Petros Pharmaceuticals, Inc. Temporary Equity, Liquidation Preference
Petros Pharmaceuticals, Inc. (PTPI) had Temporary Equity, Liquidation Preference of $1.26 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2024-11-13
- 2024-09-30: Temporary Equity, Liquidation Preference $1.26M.
- 2024-06-30: Temporary Equity, Liquidation Preference $4.59M.
- 2024-03-31: Temporary Equity, Liquidation Preference $6.39M.
- 2023-12-31: Temporary Equity, Liquidation Preference $11.27M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2024-09-30 | $1.26M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.59M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.39M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $11.27M 10-Q · filed 2024-11-13 |
| 2023-09-30 | $15.00M 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |